Clinical Trial Update: Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares rituximab with oral cyclophosphamide for severe mucous membrane pemphigoid and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucous Membrane Pemphigoid

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Severe Forms of Mucous Membrane Pemphigoid | Phase 3 | Status: RECRUITING